News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Troubled AstraZeneca PLC (AZN) Should Consider Merging With Abbvie: Analysts


6/20/2012 8:15:38 AM

Analysts want Abbott’s new spin-off firm AbbVie to merge with the troubled AstraZeneca, saying it could give both firms future value. AbbVie will be the new R&D firm coming from Abbott’s split into two new companies, and is scheduled to go ahead within the next year. The firm will rely on its Humira brand in the short-term - which will become the world’s biggest selling drug this year - but could need more to beef-up its future prospects when the auto-inflammatory treatment goes off patent.

Read at InPharm.com
Read at Guardian
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES